Interni a diabetologicka ordinace s.r.o.
- Address
- Nemcove 738, 547 01 Nachod, Czechia
Interni a diabetologicka ordinace s.r.o. - Metabolic and Cardiovascular Research
Interni a diabetologicka ordinace s.r.o. is a specialized internal medicine and diabetology clinical research center dedicated to advancing therapeutic interventions for metabolic disorders and their cardiovascular complications. The center focuses on investigating innovative treatments that address the complex interplay between metabolic health and cardiovascular safety.
- Cardiovascular safety evaluation in obesity and metabolic disease management
- Novel pharmacological interventions for weight management and obesity treatment
- Assessment of major adverse cardiovascular events (MACE) in at-risk populations
The research center conducts comprehensive studies examining cardiovascular outcomes in patients with obesity and overweight, with particular emphasis on evaluating endpoints such as cardiovascular death, myocardial infarction, stroke, and heart failure events. Their expertise in diabetology and internal medicine positions them to evaluate the long-term safety and efficacy of emerging therapeutic agents targeting metabolic dysfunction while ensuring optimal cardiovascular protection.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Kailera Therapeutics Inc.2active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Kailera Therapeutics Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Interni a diabetologicka ordinace s.r.o.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impactof Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV) | Amgen Inc. | Phase III | Recruiting | Oct 2025 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| HRS 9531 | 2 | Unknown | 2026-06-16 | 2026-06-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.